article · Journal of Herbmed Pharmacology
Introduction: The increase in antimicrobial resistance has necessitated the screening of medicinal plants as potential agents for the treatment of microbial infections. The aim of the research was to explore antimicrobial activities of identified local plants, namely: Kigelia africana, Maytenus chasei, Ximenia caffra, and Schrebera alata. Methods: The powdered leaves of the selected plants were extracted using ethanol, hexane, ethyl acetate, methanol, and water as solvents, and phytochemical contents were determined. DPPH (1,1-diphenyl-2-picrylhydrazyl) assay was used to determine the antioxidant activities of the extracts. Plant extracts were tested against bacterial ATCC strains for their antimicrobial properties. Results: Hexane and water extracts of K. africana showed the highest percentage yield (16.15% and 8.85%, respectively). The highest phenolic content was found in water extracts of S. alata (14.07 ± 4.8 mg/g) and ethanol extracts of M. chasei (8.6 ± 1.53 mg/g), while the highest flavonoid content was found in the ethyl acetate extract of M. chasei (997.34 ± 52.04 mg/g). For all the tested plant extracts, the ethanol extract of M. chasei showed the best IC50 value of ± 4.71 µg/mL against DPPH compared to other plant extracts. The water extracts of all the tested plants also showed high antioxidant activities. Extracts of X. caffra and S. alata showed comparable inhibitions to ciprofloxacin (P>0.05) against all tested organisms. Conclusion: The findings of the study suggest that the compounds in the plant extracts contained both antioxidant and antibacterial activities and these plants might be considered for the treatment of bacterial infections.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.34172/jhp.2024.44481
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.